SLOAD

SLOAD identifies cancer-specific synthetic lethal interactions by integrating DNA mutations, copy number variations (CNVs), methylation patterns, and mRNA expression data to predict genetic interactions for precision oncology.

Key Features:

• Multi-Omics Integration: Integrates DNA mutations, copy number variations (CNVs), methylation patterns, and mRNA expression profiles for holistic analysis of genetic interactions.
• Predictive Modeling with Random Forest: Applies a random forest algorithm to predict cancer-specific synthetic lethal interactions.
• Candidate Gene-Pair Analysis: Analyzes candidate gene pairs derived from public datasets to identify potential synthetic lethal relationships.
• Pan-Cancer Analysis: Supports pan-cancer comparative analysis to assess synthetic lethal interactions across multiple cancer types.
• Database of Cancer-Specific Interactions: Compiles predicted and curated cancer-specific synthetic lethal interaction records across cancer types.

Scientific Applications:

• Precision Oncology Target Discovery: Identifies cancer-specific inactive genes and their synthetic lethal partners to prioritize targets for selective elimination of cancer cells.
• Drug Discovery and Development: Provides candidate synthetic lethal targets to guide development of therapeutics aimed at improving efficacy and reducing toxicity.
• Pan-Cancer Comparative Studies: Enables comparative investigation of synthetic lethal interactions across cancer types to inform personalized treatment strategies.

Methodology:

Integration of DNA mutation, CNV, methylation, and mRNA expression data; analysis of candidate gene pairs from public datasets; predictive modeling using random forest; pan-cancer comparative analysis.